Listen for Patients on Hep C Meds Reporting Serious Liver Problems

You'll hear about a link between hepatitis C meds and liver damage...especially in patients who also have hepatitis B.

FDA now requires a boxed warning about the risk of hepatitis B reactivation with newer hep C meds...Epclusa, Harvoni, Zepatier, etc.

And a recent report from Institute for Safe Medication Practices warns about rare cases of liver injury and failure tied to these meds.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote